瑞格列奈联合阿卡波糖治疗2型糖尿病疗效观察
Effect of repaglinide combined with acarbose in the treatment of type 2 diabetes mellitus
-
摘要: 目的:探讨瑞格列奈联合阿卡波糖治疗2型糖尿病的效果。方法:选取86例2型糖尿病患者,随机分为对照组和观察组各43例,对照组给予瑞格列奈治疗,观察组在对照组的基础上加用阿卡波糖,均连续治疗4周,比较2组临床治疗效果、主要生理指标变化及安全性。结果:治疗后,对照组临床总有效率76.7%,低于观察组的97.7%(PPP>0.05)。结论:瑞格列奈联合阿卡波糖治疗2型糖尿病可显著改善患者的主要生理指标参数,提高临床治疗效果,且安全性较好。Abstract: Objective:To explore the effects of repaglinide combined with acarbose in the treatment of type 2 diabetes mellitus.Methods:Eighty-six patients with type 2 diabetes were randomly divided into the control group and observation group,43 cases in each group.The control group and observation group were treated with repaglinide and repaglinide combined with acarbose for 4 weeks,respectively.The clinical effects,changes of pysiological idexes and safety between two groups were compared.Results:After treatment,the clinical total effective rates in control group and observation group were 76.7% and 97.7%,respectively,the difference of which was statistically significant(PPP>0.05).Conclusions:The treatment of type 2 diabetes with repaglinide combined with acarbose can significantly improve the main physiological indexes and clinical treatment effects,and the safety of which is good.